RETRACTION: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer (Retraction of Vol 11, art no 1061, 2020)

被引：1
|
作者：
Tan, Xiao
Zhang, Zhongqiang
Liu, Ping
Yao, Hongliang
Shen, Liangfang
Tong, Jing-Shan
机构：
[1] Xiangya Hospital,Department of Oncology
[2] Central South University,Department of Liver Transplantation
[3] The Second Xiangya Hospital of Central South University,Department of General Surgery
[4] The Second Xiangya Hospital of Central South University,Department of Pharmacology and Chemical Biology
[5] University of Pittsburgh School of Medicine,undefined
来源：
CELL DEATH & DISEASE | 2023年 / 14卷 / 03期
关键词：
D O I：
10.1038/s41419-023-05764-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] RETRACTION: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway (Retraction of Vol 11, art no 665105, 2021)
    Wang, X.
    Dai, Y.
    Zhao, Y.
    Li, M.
    Zhang, J.
    Ci, Y.
    Wang, H.
    Li, X.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] RETRACTION: A water-stable and biofriendly Zn-MOF with pyrazine decorated pores as 5-Fu delivery system to induce human ovarian cancer cells apoptosis and abrogate their growth (Retraction of Vol 1204, art no 127477, 2020)
    Yan, Zhonghua
    Li, Xiaohui
    Fan, Qianqian
    Bai, Hua
    Wu, Suhui
    Zhang, Zhi-Fang
    Pan, Lei
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1275
  • [23] RETRACTION: MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-mediated methylation of STAT3 (Retraction of Vol 11, art no 907, 2020)
    Wang, J.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] RETRACTION: Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes (Retraction of Vol 19, Pg 1164, 2020)
    Yang, Jiebin
    Lian, Yikai
    Yang, Renzhi
    Lian, Yifan
    Wu, Jingtong
    Liu, Jingjing
    Wang, Keming
    Xu, Hongzhi
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (01):
  • [25] RETRACTION: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2 (Retraction of Vol 20, art no 204, 2020)
    Sun, Dan
    Wang, Ying
    Wang, Huan
    Xin, Yan
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [26] RETRACTION: Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelialmesenchymal transition, migration, and on the pro-inflammatory phenotype (Retraction of Vol 11, art no 173, 2019)
    Stazi, Giulia
    Taglieri, Ludovica
    Nicolai, Alice
    Romanelli, Annalisa
    Fioravanti, Rossella
    Morrone, Stefania
    Sabatino, Manuela
    Ragno, Rino
    Taurone, Samanta
    Nebbioso, Marcella
    Carletti, Raffaella
    Artico, Marco
    Valente, Sergio
    Scarpa, Susanna
    Mai, Antonello
    CLINICAL EPIGENETICS, 2023, 15 (01)
  • [27] RETRACTION: MicroRNA-199a-5p suppresses the cell growth of colorectal cancer by targeting oncogene Caprin1 (Retraction of Vol 10, art no 453, 2020)
    Yu, Xiangyang
    He, Yanfang
    Wang, Yan
    Tang, Yajuan
    Guo, Yanjuan
    Yuan, Jinling
    Bai, Jinghe
    Yao, Tao
    Wu, Xiongzhi
    3 BIOTECH, 2022, 12 (11)
  • [28] RETRACTION: PNU-74654 enhances the antiproliferative effects of 5-FU in breast cancer and antagonizes thrombin-induced cell growth via the Wnt pathway
    Rahmani, F.
    Amerizadeh, F.
    Hassanian, S. M.
    Hashemzehi, M.
    Nasiri, S-N
    Fiuji, H.
    Ferns, G. A.
    Khazaei, M.
    Avan, A.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2024, 239 (12)
  • [29] RETRACTION: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer (Retraction of Vol 11, art no 43, 2020)
    Han, Mingli
    Hu, Jianguo
    Lu, Pengwei
    Cao, Hui
    Yu, Chao
    Li, Xiangke
    Qian, Xueke
    Yang, Xue
    Yang, Yunqing
    Han, Na
    Dou, Dongwei
    Zhang, Fan
    Ye, Mulin
    Yang, Changcheng
    Gu, Yuanting
    Dong, Huaying
    CELL DEATH & DISEASE, 2023, 14 (11)
  • [30] RETRACTION: lncRNA IGF2-AS Promotes Cell Proliferation, Migration, and Invasion of Gastric Cancer by Modulating miR-937/EZH2 Axis (Retraction of Vol 25, 10.1089/CBR.2019.3275, 2020)
    Li, Zizi
    Li, Zhanyu
    Zhong, Zhijuan
    Zhou, Jianhui
    Huang, Shenhao
    Zhou, Wenying
    Xu, Jianfeng
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2020, 35 (08) : 628 - 628
12345